MAbSilico enables its partners to identify the best lead candidates faster and better. Our epitope-driven antibody design uses multi-parametric approaches to design antibodies, while taking into account affinity, specificity, manufacturability, and safety all at once.
From the structural analysis of your target, MAbSilico designs antibody candidates in 21 days on a predefined epitope. We ensure that all the sequences fulfill the project's specifications (affinity, cross-species reactivity, specificity, manufacturability). Freedom-to-operate is evaluated for all sequences. The candidates are validated with wet-lab assays before being delivered to our partners.
Proprietary algorithms for docking and affinity modeling
Anticipate pre-clinical assays with best candidates
No bad surprise for development with manufacturability specifications
MAbSilico toolbox is there to support your discovery programs: speed-up the characterization of your antibodies, increase your knowledge on your target and your competitors, and strengthen your IP.